Correlation of T-lymphocyte subpopulations with immunological markers in HIV-1-infected Indian patients

Clinical Immunology

Volumn 119, Issue 3, 2006, Pages 330-338

  Kaushik, Shweta ^a   Vajpayee, Madhu ^a   Sreenivas, V ^b   Seth, Pradeep ^a  

^a HIV   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

HIV 1; Immune activation; India; T lymphocyte subsets

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; CD38 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; HLA DR ANTIGEN; L SELECTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCULATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INDIAN; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INDIA; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 33646418982     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2005.12.014     Document Type: Article

References (41)

1. McCune J.M. The dynamics of CD4+ T-cell depletion in HIV-disease. Nature Insight 410 (2001) 974-979 (Review articles)
2. Anderson R.W., Ascher M.S., and Sheppard H.W. Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: a worst case dynamic analysis. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 17 3 (1998) 245-252
3. Lang W., Perkins H., Anderson R.E., et al. Patterns of T lymphocyte changes with human immunodeficiency infection: from seroconversion to development of AIDS. J. Acquired Immune Defic. Syndr. 2 (1989) 63-69
4. Benito J.M., Zabay J.M., Gill J., et al. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14 2 (1997) 128-135
5. Hellerstein M., Hanley M.B., Cesar D., et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1 infected humans. Nat. Med. 5 1 (1999) 83-89
6. Kovacs J.A., Lempicki R.A., Sidorov I.A., et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J. Exp. Med. 194 12 (2001) 1731-1741
7. Hazenberg M.D., Stuart J.W., Otto S.A., et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95 1 (2000) 249-255
8. Bofill M., Akbar A.N., Salmon M., et al. Immature CD45RA (low) RO (low) T cells in the human cord blood. I Antecedents of CD45RA+ unprimed T cells. J. Immunol. 152 (1994) 5613-5623
9. Bell E.B., Sparshott S.M., Bunce C., et al. CD4+ T cell memory, CD45R subsets and the persistence of antigen - a unifying concept. Immunol. Today 19 (1998) 60-64
10. Butcher E.C., and Picker L.J. Lymphocyte homing and homeostasis. Science 272 5258 (1996) 60-66
11. McCune J.M., Loftus R., Schmidt D.K., et al. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J. Clin. Invest. 101 11 (1998) 2301-2308
12. Smith K.Y., Valdez H., Landay A., et al. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J. Infect. Dis. 181 1 (2000) 141-147
13. Douek D.C., McFarland R.D., Keiser P.H., et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 396 6712 (1998) 690-695
14. Nowak M.A., Lloyd M.A., Vasquez G.M., et al. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J. Virol. 71 10 (1997) 7518-7525
15. Tedla N., Palladinetti P., Kelly M., et al. Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. Am. J. Pathol. 148 5 (1996) 1367-1373
16. Pakker N.G., Notermans D.W., de Boer R.J., et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat. Med. 4 2 (1998) 208-214
17. Gorochov G., Neumann A.U., Kereveur A., et al. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD49 repertoire during antiviral therapy. Nat. Med. 4 2 (1998) 215-221
18. Champagne P., Ogg G.S., King A.S., et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410 6824 (2001) 106-111
19. Levacher M., Hulstaert F., Tallet S., et al. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin. Exp. Immunol. 90 3 (1992) 376-382
20. Phillips A.N., Sabin C.A., Elford J., et al. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up. AIDS 7 7 (1993) 975-980
21. Peakman M., Mahalingam M., Pozinak A., et al. Markers of immune activation and disease progression. Cell activation in HIV disease. Adv. Exp. Med. Biol. 374 (1995) 17-26
22. Kestens L., Vanham G., Gigase P., et al. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocyte during HIV-1 infection. AIDS 6 (1992) 793-797
23. Mehta K., Shahid U., and Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J. 10 12 (1996) 1408-1417
24. Deaglio S., Morra M., Mallone R., et al. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J. Immunol. 160 (1998) 395-402
25. Mocroft A., Bofill M., Lipman M., et al. CD8+CD38+ lymphocyte percents: a useful immunological marker for monitoring HIV-1 infected patients. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14 2 (1997) 158-162
26. Navarro J., Resino S., Bellon J.M., et al. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 17 10 (2001) 525-532
27. Bouscarat F., Levacher C.M., Dazza M.C., et al. Correlation of CD8+ lymphocytes activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 12 1 (1996) 17-24
28. Resino S., Bellon J.M., Gurbindo M.D., et al. CD38 expression in CD8+ T cells predicts virologic failure in HIV type 1-infected children receiving antiretroviral therapy. Clin. Infect. Dis. 38 3 (2004) 412-417
29. Giorgi J.V., Ho H.N., Hirji K., et al. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+CD38-CD8+ cells is associated with subsequent stable CD4+ cell levels. J. Infect. Dis. 170 4 (1994) 775-781
30. CDC. 1992 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 RR-17 (1993) 961-962
31. CDC. 1997 revised guidelines for performing CD4+ T-Cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR 46 RR-2 (1997) 1-29
32. Vithayasai V., Sirisanthana T., Sakonwasun C., et al. Flow cytometric analysis of T lymphocyte subsets in adult Thais. Asian Pac. J. Allergy Immunol. 15 3 (1997) 141-146
33. Resino S., Navarro J., Bellon M., et al. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART. Clin. Exp. Immunol. 125 (2001) 266-273
34. Resino S., Gurbindo D., Cano J.M.B., et al. Predictive markers of clinical outcome in vertically HIV-1-infected infants. A prospective longitudinal study. Pediatr. Res. 47 4 (2000) 509-515
35. Bishop D.K., Ferguson R.M., and Orosz C.G. Differential distribution of antigen-specific helper T cells and cytotoxic T cells after antigenic stimulation in vivo. J. Immunol. 144 4 (1990) 1153-1160
36. Rabil R.L., Roederer M., Maldonado Y., et al. Altered representation of naïve and memory T cell subsets in HIV infected children. J. Clin. Invest. 95 5 (1995) 2054-2060
37. Roederer M., Dubs J.G., Anderson M.T., et al. CD8 naïve T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 95 5 (1995) 2061-2066
38. Bujdoso R., Young P., Hopkins J., et al. Non-random migration of CD4 and CD8 T cells: changes in CD4:CD8 ratios and interleukin-2 responsiveness of efferent lymph node cells following in vivo antigen challenge. Eur. J. Immunol. 19 10 (1989) 1779-1784
39. Koblavi-Deme S., Maran M., Kabran N., et al. Changes in levels of immune activation and reconstitution markers among HIV-1 infected Africans receiving antiretroviral therapy. AIDS 17 Suppl. 3 (2003) S17-S22
40. Hunt P.W., Martin J.N., Sinclair E., et al. T cell activation is associated with lower CD4+ T cell giants in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 187 10 (2003) 1534-1543
41. Ondoa P., Koblavi-Deme S., Borget Y.M., et al. Assessment of CD8+ T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Cote d'Ivoire. Clin. Exp. Immunol. 140 1 (2005) 138-148